TrialThe Lancet. Oncology2023

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.

Linda R Mileshkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.